THE EVALUATION OF THE DEVELOPMENTAL TOXICITY OF HYDROCHLOROTHIAZIDE IN MICE AND RATS

Citation
Jd. George et al., THE EVALUATION OF THE DEVELOPMENTAL TOXICITY OF HYDROCHLOROTHIAZIDE IN MICE AND RATS, Fundamental and applied toxicology, 26(2), 1995, pp. 174-180
Citations number
29
Categorie Soggetti
Toxicology
ISSN journal
02720590
Volume
26
Issue
2
Year of publication
1995
Pages
174 - 180
Database
ISI
SICI code
0272-0590(1995)26:2<174:TEOTDT>2.0.ZU;2-A
Abstract
Timed-pregnant CD-1 outbred albino Swiss mice and CD Sprague-Dawley ra ts were administered hydrochlorothiazide (HCTZ, USP) in corn oil by ga vage during major organogenesis, Gestational Days (GD) 6 through 15. T he doses administered were 0, 300, 1000, or 3000 mg/kg/day for mice an d 0, 100, 300, or 1000 mg/kg/day for rats. Maternal clinical status wa s monitored daily during treatment. At termination (GD 17, mice; GD 20 , rats), confirmed pregnant females (20-27 per group, mice; 36-39 per group, rats) were evaluated for clinical status and gestational outcom e; each live fetus was examined for external, visceral, and skeletal m alformations. In mice, no maternal mortality was observed. However, cl inical signs including dehydration, piloerection, lethargy, and single -day weight loss appeared to be dose-related. HCTZ had no effect on ma ternal weight gain or water consumption, gravid uterine weight, relati ve maternal liver weight, or relative maternal kidney weight. There wa s no definitive evidence of embryotoxicity or fetal toxicity for mice on GD 17. Thus, the no observed adverse effect level (NOAEL) for both maternal and developmental toxicity was 3000 mg/kg/day. In rats, HCTZ had no effect on maternal survival, clinical signs, or water consumpti on. Clinical signs were not dose-related. Maternal weight gain during treatment was depressed at 1000 mg/kg/day. Gravid uterine weight and r elative maternal liver weight were unaffected. Relative maternal kidne y weight was slightly (7-8%) increased at all dose levels, but there w as no evidence of a dose response. Thus, the maternal NOAEL for rats w as 300 mg/kg/day, based on decreased maternal weight gain during treat ment at 1000 mg/kg/day. HCTZ had no effect on prenatal mortality, feta l growth, or morphological development in rats. The developmental NOAE L was greater than or equal to 1000 mg/kg/day. In summary, oral admini stration of HCTZ to mice at doses up to 3000 mg/kg/day and rats at dos es up to 1000 mg/kg/day during organogenesis produced no evidence of d evelopmental toxicity in either species, in spite of mild maternal tox icity in rats at 1000 mg/kg/day. (C) 1995 Society of Toxicology.